Welcome

Sign out Have a question? We're here to help

Copyright © 2020 InvestorPlace Media, LLC. All rights reserved. 9201 Corporate Blvd, Rockville, MD 20850.

Mirati Therapeutics (MRTX)

$92.17 2.43 (2.57%)

16:59 EST MRTX Stock Quote Delayed 15 Minutes

Volume:

Previous Close $92.17

Market Cap 2.97B

PE Ratio -35.96

EPS -2.562953

Volume (Avg. Vol.) 196,600

Day's Range 91.39 - 95.03

52-Week Range 55.11 - 132.59

Dividend & Yield N/A (N/A)

MRTX Stock Predictions, Articles, and Mirati Therapeutics News

From InvestorPlace
From the Web

The 10 Best Stocks for 2019 — So Far

By James Brumley, InvestorPlace Feature Writer Jun 4, 2019

Roku, Array Biopharma and Guardant Health are just some of the best stocks by returns for the first half of 2019.

MRTX Makes Notable Cross Below Critical Moving Average

From Market News Video Feb 14, 2020

In trading on Friday, shares of Mirati Therapeutics Inc (MRTX) crossed below their 200 day moving average of $92.80, changing hands as low as $91.39 per share. Mirati Therapeutics Inc shares are currently trading down about 2.6% on the day..

Is There An Opportunity With Mirati Therapeutics, Inc.’s (NASDAQ:MRTX) 43% Undervaluation?

From Simply Wall St Feb 7, 2020

How far off is Mirati Therapeutics, Inc. (NASDAQ:MRTX) from its intrinsic value? Using the most recent financial data, we’ll take a look at whether the stock is fairly priced by<div><a class="permalink" href="https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-mrtx/mirati-therapeutics/news/is-there-an-opportunity-with-mirati-therapeutics-inc-s-nasdaqmrtx-43-undervaluation/">Read More...</a></div>

Oversold Conditions For Mirati Therapeutics (MRTX)

From Market News Video Jan 31, 2020

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100..

Benzinga's Top Upgrades, Downgrades For January 28, 2020

From Benzinga Jan 28, 2020

Upgrades Morgan Stanley changed the rating for Janus Henderson Group PLC (NYSE: JHG) from Equal-Weight to Overweight. For the third quarter, Janus Henderson Gr had an...

Best & Worst Performing Mid Cap Stocks for January 24, 2020

From StockNews.com Jan 24, 2020

EHTH – EHTH leads the way today as the best performing mid cap stock, closing up 26.90%.

MRTX Crosses Below Key Moving Average Level

From Market News Video Jan 23, 2020

In trading on Thursday, shares of Mirati Therapeutics Inc (MRTX) crossed below their 200 day moving average of $90.74, changing hands as low as $87.69 per share. Mirati Therapeutics Inc shares are currently trading down about 1.2% on the day..

Navellier Ratings

Powered by Portfolio Grader

Total Grade

C

Hold